X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (84) 84
humans (82) 82
hematology (67) 67
male (51) 51
article (49) 49
middle aged (49) 49
aged (47) 47
female (44) 44
adult (43) 43
oncology (42) 42
aged, 80 and over (29) 29
treatment outcome (23) 23
leukemia (22) 22
chronic lymphocytic leukemia (21) 21
hematology, oncology and palliative medicine (20) 20
patients (18) 18
survival (18) 18
young adult (18) 18
follow-up studies (17) 17
therapy (17) 17
abridged index medicus (15) 15
adolescent (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
dasatinib (15) 15
leukemia, lymphocytic, chronic, b-cell - drug therapy (15) 15
mutation (15) 15
cancer (14) 14
care and treatment (14) 14
disease-free survival (14) 14
prognosis (14) 14
retrospective studies (14) 14
rituximab (14) 14
antineoplastic agents - therapeutic use (13) 13
bone marrow - pathology (13) 13
hemic and lymphatic diseases (13) 13
leukemia, lymphocytic, chronic, b-cell - pathology (13) 13
lymphomas (13) 13
cll (12) 12
ibrutinib (12) 12
lymphoma (11) 11
protein kinase inhibitors - therapeutic use (11) 11
survival rate (11) 11
chronic myeloid leukemia (10) 10
diagnosis (10) 10
imatinib (10) 10
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (10) 10
nilotinib (10) 10
recurrence (10) 10
survival analysis (10) 10
tyrosine (10) 10
chronic lymphatic leukemia (9) 9
disease progression (9) 9
minimal residual disease (9) 9
patient outcomes (9) 9
pyrimidines - therapeutic use (9) 9
transformation (9) 9
tyrosine kinase inhibitors (9) 9
chronic lymphocytic-leukemia (8) 8
health aspects (8) 8
leukemia, lymphocytic, chronic, b-cell - diagnosis (8) 8
leukemia, lymphocytic, chronic, b-cell - genetics (8) 8
leukemia, myeloid, chronic-phase - drug therapy (8) 8
chemotherapy (7) 7
chronic myelogenous leukemia (7) 7
clinical trials (7) 7
cml (7) 7
expression (7) 7
leukemia, lymphocytic, chronic, b-cell - mortality (7) 7
lymphatic leukemia (7) 7
mutations (7) 7
protein-tyrosine kinase (7) 7
pyrazoles - therapeutic use (7) 7
pyrimidines - administration & dosage (7) 7
remission induction (7) 7
risk factors (7) 7
transplantation (7) 7
trial (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
cyclophosphamide - administration & dosage (6) 6
immunotherapy (6) 6
leukemia, myelogenous, chronic, bcr-abl positive - mortality (6) 6
lymphoma, large b-cell, diffuse - pathology (6) 6
medicine & public health (6) 6
protein kinase inhibitors - administration & dosage (6) 6
risk (6) 6
stem cell transplantation (6) 6
stem cells (6) 6
analysis (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
bcr-abl (5) 5
btk (5) 5
clinical trials as topic (5) 5
combined modality therapy (5) 5
genetic aspects (5) 5
leukemia, lymphocytic, chronic, b-cell - metabolism (5) 5
leukemia, myeloid, chronic-phase - mortality (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
mantle cell lymphoma (5) 5
microenvironment (5) 5
multivariate analysis (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 06/2019, Volume 94, Issue 6, pp. 710 - 725
Unprecedented advances in our understanding of the pathobiology, prognostication, and therapeutic options in mantle cell lymphoma (MCL) have taken place in the... 
INTRINSIC IBRUTINIB RESISTANCE | NERVOUS-SYSTEM INVOLVEMENT | 15-YEAR FOLLOW-UP | BRUTON TYROSINE KINASE | PROGRESSION-FREE SURVIVAL | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | PHASE-II | HIGH-DOSE CYTARABINE | HEMATOLOGY | MINIMAL RESIDUAL DISEASE
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2016, Volume 91, Issue 3, pp. 330 - 340
Journal Article
Journal Article
American journal of hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 1113 - 1114
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 01/2014, Volume 11, Issue 1, pp. 6 - 8
A landmark study has delineated and identified the genetic pathways that drive the natural course of chronic lymphocytic leukaemia (CLL) B cells into Richter's... 
Genetic aspects | Diagnosis | Gene mutations | Identification and classification | Richter's syndrome
Journal Article
Expert Opinion in Biological Therapy, ISSN 1471-2598, 02/2013, Volume 13, Issue 2, pp. 169 - 182
Introduction: The last decade has witnesd immense progress in the treatment of chronic lymphocytic leukemia (CLL). Chemoimmunotherapy (CIT) combining rituximab... 
Fc receptors | Chronic lymphatic leukemia | Cyclophosphamide | Conferences | Clinical trials | Monoclonal antibodies | fludarabine | Oncology | rituximab
Journal Article
Blood, ISSN 0006-4971, 03/2010, Volume 115, Issue 9, pp. 1668 - 1668
Journal Article
International Journal of Hematology, ISSN 0925-5710, 07/2013, Volume 98, Issue 1, pp. 3 - 3
Journal Article